Evidence map›Paper›PMID 35707035›Full record

ArticleFrontiers in neurology2022

Screening of the

Ling-Yan Ma, Lin Han, Meng Niu, Lu Chen, Ya-Zhen Yu, Tao Feng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Ling-Yan MaDepartment of Neurology, Center for Movement Disorders, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Lin HanRunning Gene Inc., Beijing, China.
Meng NiuDepartment of Neurology, Hengshui Eighth People's Hospital, Hebei, China.
Lu ChenDepartment of Encephalopathy, Dong Fang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Ya-Zhen YuDepartment of Pediatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Tao FengDepartment of Neurology, Center for Movement Disorders, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Beijing University of Chinese Medicine · CNCapital Medical University · CNChinese Institute for Brain Research · CNHengshui University · CNNational Clinical Research Center for Digestive Diseases · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Paroxysmal kinesigenic dyskinesia (PKD) is a rare neurological disorder characterized by recurrent involuntary movements usually triggered by sudden movements. Mutations in the Methods: To investigate the genetic basis of PKD and broaden the clinical spectrum of the Results: Two novel variants of the Conclusions: This study further validated the role of

Indexed as

dystoniaparoxysmal exercise-induced dyskinesia (PED)paroxysmal kinesigenic dyskinesia (PKD)paroxysmal non-kinesigenic dyskinesia (PNKD)TMEM151A genewhole-exome sequencing (WES)

Identifiers

PMID35707035
PMCPMC9189402
OpenAlexW4281648758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.